2,284
Views
0
CrossRef citations to date
0
Altmetric
Clinical Research Article

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder

Evidencia preliminar de la importancia de la alianza terapéutica en la psicoterapia asistida con MDMA para el trastorno de estrés postraumático

, , , , , & show all
Article: 2297536 | Received 19 Jun 2023, Accepted 14 Dec 2023, Published online: 04 Jan 2024

References

  • Agin-Liebes, G., Zeifman, R. J., Luoma, J. B., Garland, E. L., Campbell, W. K., & Weiss, B. (2022). Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. Journal of Psychopharmacology, 36(3), 295–308. https://doi.org/10.1177/02698811221080165
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.
  • American Psychological Association. (2017). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. http://www.apa.org/about/offices/directorates/guidelines/ptsd.pdf
  • Bedi, G., Phan, K. L., Angstadt, M., & De Wit, H. (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology, 207(1), 73–83. https://doi.org/10.1007/s00213-009-1635-z
  • Bershad, A. K., Mayo, L. M., Van Hedger, K., McGlone, F., Walker, S. C., & de Wit, H. (2019). Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Neuropsychopharmacology, 44(10), 1698–1705. https://doi.org/10.1038/s41386-019-0402-z
  • Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Klauminzer, G., Charney, D. S., & Keane, T. M. (1990). A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1. Behavior Therapist, 13, 187–188.
  • Bordin, E. S. (1979). The generalizability of the psychoanalytic concept of the working alliance. Psychotherapy: Theory, Research & Practice, 16(3), 252–260. https://doi.org/10.1037/h0085885
  • Boritz, T. Z., Zeifman, R. J., & McMain, S. F. (2018). Mechanisms of change in dialectical behavior therapy. In M. Swales (Ed.), The Oxford handbook of dialectical behaviour therapy (pp. 515–532). Oxford University Press.
  • Bryant, R. A. (2019). Post-traumatic stress disorder: A state-of-the-art review of evidence and challenges. World Psychiatry, 18(3), 259–269. https://doi.org/10.1002/wps.20656
  • Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018). Psychedelics and the essential importance of context. Journal of Psychopharmacology, 32(7), 725–731. https://doi.org/10.1177/0269881118754710
  • Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum Associates Inc.
  • Crowe, T. P., & Grenyer, B. F. S. (2008). Is therapist alliance or whole group cohesion more influential in group psychotherapy outcomes? Clinical Psychology & Psychotherapy, 15(4), 239–246. https://doi.org/10.1002/cpp.583
  • Davis, A. K., Barrett, F. S., So, S., Gukasyan, N., Swift, T. C., & Griffiths, R. R. (2021). Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology, 35(4), 437–446. https://doi.org/10.1177/0269881120967878
  • Eubanks, C. F., Burckell, L. A., & Goldfried, M. R. (2018). Clinical consensus strategies to repair ruptures in the therapeutic alliance. Journal of Psychotherapy Integration, 28(1), 60–76. https://doi.org/10.1037/int0000097
  • Feduccia, A. A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2019). Breakthrough for trauma treatment: Safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Frontiers in Psychiatry, 10, 650. https://doi.org/10.3389/fpsyt.2019.00650
  • Flückiger, C., Del Re, A. C., Wampold, B. E., & Horvath, A. O. (2018). The alliance in adult psychotherapy: A meta-analytic synthesis. Psychotherapy, 55(4), 316–340. https://doi.org/10.1037/pst0000172
  • Gabry, J., & Goodrich, B. (2017). rstanarm: Bayesian Applied Regression Modeling via Stan. R package version 2.15.3. https://CRAN.R-project.org/package=rstanarm
  • Gukasyan, N., & Nayak, S. M. (2022). Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy. Transcultural Psychiatry, 59(5), 652–664. https://doi.org/10.1177/1363461520983684
  • Haijen, E. C., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., & Carhart-Harris, R. L. (2018). Predicting responses to psychedelics: A prospective study. Frontiers in Pharmacology, 9, 897. https://doi.org/10.3389/fphar.2018.00897
  • Heckman, T. G., Heckman, B. D., Anderson, T., Bianco, J. A., Sutton, M., & Lovejoy, T. I. (2017). Common factors and depressive symptom relief trajectories in group teletherapy for persons ageing with HIV. Clinical Psychology & Psychotherapy, 24(1), 139–148. https://doi.org/10.1002/cpp.1989
  • Horvath, A. O., & Greenberg, L. S. (1989). Development and validation of the working alliance inventory. Journal of Counseling Psychology, 36(2), 223–233. https://doi.org/10.1037/0022-0167.36.2.223
  • Howard, R., Berry, K., & Haddock, G. (2022). Therapeutic alliance in psychological therapy for posttraumatic stress disorder: A systematic review and meta-analysis. Clinical Psychology & Psychotherapy, 29(2), 373–399. https://doi.org/10.1002/cpp.2642
  • Jardim, A. V., Jardim, D. V., Chaves, B. R., Steglich, M., Ot’alora, G. M., Mithoefer, M. C., da Silveira, D. X., Tófoli, L. F., Ribeiro, S., Matthews, R., Doblin, R., & Schenberg, E. E. (2021). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: An open label pilot study in Brazil. Brazilian Journal of Psychiatry, 43(2), 181–185. https://doi.org/10.1590/1516-4446-2020-0980
  • Kettner, H., Rosas, F. E., Timmermann, C., Kärtner, L., Carhart-Harris, R. L., & Roseman, L. (2021). Psychedelic communitas: Intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness. Frontiers in Pharmacology, 12, 623985. https://doi.org/10.3389/fphar.2021.623985
  • Kruschke, J. (2015). Doing Bayesian data analysis: A tutorial with R, JAGS, and Stan (2nd ed.). Academic Press.
  • Krystal, J. H., Davis, L. L., Neylan, T. C., Raskind, M. A., Schnurr, P. P., Stein, M. B., Vessicchio, J., Shiner, B., Gleason, T. D., & Huang, G. D. (2017). It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: A consensus statement of the PTSD psychopharmacology working group. Biological Psychiatry, 82(7), e51–e59. https://doi.org/10.1016/j.biopsych.2017.03.007
  • Makowski, D., Ben-Shachar, M. S., Chen, S. A., & Lüdecke, D. (2019). Indices of effect existence and significance in the Bayesian framework. Frontiers in Psychology, 10, 2767. https://doi.org/10.3389/fpsyg.2019.02767
  • Makowski, D., Ben-Shachar, M. S., & Lüdecke, D. (2019). bayestestR: Describing effects and their uncertainty, existence and significance within the Bayesian framework. Journal of Open Source Software, 4(40), 1541. https://doi.org/10.21105/joss.01541
  • McNeish, D. (2016). On using Bayesian methods to address small sample problems. Structural Equation Modeling: A Multidisciplinary Journal, 23(5), 750–773. https://doi.org/10.1080/10705511.2016.1186549
  • Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora, M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mitoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., … Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025–1033. https://doi.org/10.1038/s41591-021-01336-3
  • Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. (2016). Novel psychopharmacological therapies for psychiatric disorders: Psilocybin and MDMA. The Lancet Psychiatry, 3(5), 481–488. https://doi.org/10.1016/S2215-0366(15)00576-3
  • Mithoefer, M. C., Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazzar Klosinski, B., Emerson, A., & Doblin, R. (2018). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: A randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry, 5(6), 486–497. https://doi.org/10.1016/S2215-0366(18)30135-4
  • Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439–452. https://doi.org/10.1177/0269881110378371
  • Molla, H., Lee, R., Lyubomirsky, S., & de Wit, H. (2023). Drug-induced social connection: Both MDMA and methamphetamine increase feelings of connectedness during controlled dyadic conversations. Scientific Reports, 13(1), 15846. https://doi.org/10.1038/s41598-023-43156-0
  • Monson, C. M., Wagner, A. C., Mithoefer, A. T., Liebman, R. E., Feduccia, A. A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Doblin, R., & Mithoefer, M. C. (2020). MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: An uncontrolled trial. European Journal of Psychotraumatology, 11(1), 1840123. https://doi.org/10.1080/20008198.2020.1840123
  • Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kaertner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., Erritzoe, D., Watts, R., & Carhart-Harris, R. L. (2022). Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression. Frontiers in Pharmacology, 12, 788155. https://doi.org/10.3389/fphar.2021.788155
  • Oehen, P., Traber, R., Widmer, V., & Schnyder, U. (2013). A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). Journal of Psychopharmacology, 27(1), 40–52. https://doi.org/10.1177/0269881112464827
  • Ot’alora, G. M., Grigsby, J., Poulter, B., Van Derveer, J. W., III, Giron, S. G., Jerome, L., Feduccia, A. A., Hamilton, S., Yazar-Klonsinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2018). 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology, 32(12), 1295–1307. https://doi.org/10.1177/0269881118806297
  • Peill, J. M., Trinci, K. E., Kettner, H., Mertens, L. J., Roseman, L., Timmermann, C., Rosas, F. E., Lyons, T., & Carhart-Harris, R. L. (2022). Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology, 36(1), 31–45. https://doi.org/10.1177/02698811211066709
  • Pinto, R. Z., Ferreira, M. L., Oliveira, V. C., Franco, M. R., Adams, R., Maher, C. G., & Ferreira, P. H. (2012). Patient-centred communication is associated with positive therapeutic alliance: A systematic review. Journal of Physiotherapy, 58(2), 77–87. https://doi.org/10.1016/S1836-9553(12)70087-5
  • Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E. (2014). Differential effects of MDMA and methylphenidate on social cognition. Journal of Psychopharmacology, 28(9), 847–856. https://doi.org/10.1177/0269881114542454
  • Sessa, B., Higbed, L., O’Brien, S., Durant, C., Sakal, C., Titheradge, D., Williams, T. M., Rose-Morris, A., Brew-Girard, E., Burrows, S., Wiseman, C., Wilosn, S., Rickard, J., & Nutt, D. J. (2021). First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. Journal of Psychopharmacology, 35(4), 375–383. https://doi.org/10.1177/0269881121991792
  • Solomonov, N., McCarthy, K. S., Keefe, J. R., Gorman, B. S., Blanchard, M., & Barber, J. P. (2018). Fluctuations in alliance and use of techniques over time: A bidirectional relation between use of “common factors” techniques and the development of the working alliance. Clinical Psychology & Psychotherapy, 25(1), 102–111. https://doi.org/10.1002/cpp.2143
  • Traynor, J. M., Roberts, D., Ross, S., Zeifman, R., & Choi-Kain, L. (2022). MDMA-assisted psychotherapy for borderline personality disorder. Focus, 20(4), 358–367. https://doi.org/10.1176/appi.focus.20220056
  • Wagner, A. C. (2021). Couple therapy with MDMA—proposed pathways of action. Frontiers in Psychology, 12, 733456. https://doi.org/10.3389/fpsyg.2021.733456
  • Wagner, A. C., Liebman, R. E., Mithoefer, A. T., Mithoefer, M. C., & Monson, C. M. (2021). Relational and growth outcomes following couples therapy with MDMA for PTSD. Frontiers in Psychiatry, 12, 702838. https://doi.org/10.3389/fpsyt.2021.702838
  • Wang, J. B., Lin, J., Bedrosian, L., Coker, A., Jerome, I., Feduccia, A., Lilienstein, A., Harrison, C., Heimler, E., Mithoefer, M., Mithoefer, A., Ot’alora, M. G., Poulter, B., Carlin, S., Matthews, R., Yazar-Klonsinski, B., Emerson, A., & Doblin, R. (2021). Scaling up: Multisite open-label clinical trials of MDMA-assisted therapy for severe posttraumatic stress disorder. Journal of Humanistic Psychology, https://journals.sagepub.com/doi/full/10.1177/00221678211023663.
  • Wardle, M. C., & de Wit, H. (2014). MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology, 231(21), 4219–4229. https://doi.org/10.1007/s00213-014-3570-x
  • Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T., & Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM–5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486
  • Weathers, F. W., Keane, T. M., & Davidson, J. R. (2001). Clinician-administered PTSD scale: A review of the first ten years of research. Depression and Anxiety, 13(3), 132–156. https://doi.org/10.1002/da.1029
  • Weiss, D. S. (2007). The impact of event scale: Revised. In J. P. Wilson & C. S. Tang (Eds.), Cross-cultural assessment of psychological trauma and PTSD (pp. 219–238). Springer.
  • Weiss, D. S., & Marmar, C. R. (1997). The impact of event scale–revised. In J. P. Wilson & T. M. Keane (Eds.), Assessing psychological trauma and PTSD: A practitioner's handbook (pp. 399–411). Guilford Press.
  • Williams, M. T., Reed, S., & Aggarwal, R. (2019). Culturally informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder. Journal of Psychedelic Studies, 4(1), 40–50. https://doi.org/10.1556/2054.2019.016
  • Wolff, M., Mertens, L. J., Walter, M., Enge, S., & Evens, R. (2022). The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility. Journal of Psychopharmacology, 36(3), 387–408. https://doi.org/10.1177/02698811211073758
  • Wolfson, P. E., Andries, J., Feduccia, A. A., Jerome, L., Wang, J. B., Williams, E., Carlin, S. C., Sola, E., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M., & Doblin, R. (2020). MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: A randomized pilot study. Scientific Reports, 10(1), 1–15. https://doi.org/10.1038/s41598-020-75706-1
  • Woody, S. R., & Adessky, R. S. (2002). Therapeutic alliance, group cohesion, and homework compliance during cognitive-behavioral group treatment of social phobia. Behavior Therapy, 33(1), 5–27. https://doi.org/10.1016/S0005-7894(02)80003-X
  • Zeifman, R. J., Kettner, H., Pagni, B. A., Mallard, A., Roberts, D. E., Erritzoe, D., & Carhart-Harris, R. L. (2023). Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. Scientific Reports, 13(1), 13645. https://doi.org/10.1038/s41598-023-40856-5
  • Zeifman, R. J., Landy, M. S. H., Liebman, R., Fitzpatrick, S., & Monson, C. M. (2021). Optimizing treatment for comorbid borderline personality disorder and posttraumatic stress disorder: A systematic review of psychotherapeutic approaches and treatment efficacy. Clinical Psychology Review, 86, 102030. https://doi.org/10.1016/j.cpr.2021.102030
  • Zeifman, R. J., & Wagner, A. C. (2020). Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder. Journal of Contextual Behavioral Science, 15, 1–11. https://doi.org/10.1016/j.jcbs.2019.11.001
  • Zeifman, R. J., Wagner, A. C., Monson, C. M., & Carhart-Harris, R. (2023). How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change. Journal of Affective Disorders, 334, 100–112. doi:10.1016/j.jad.2023.04.105